Journal of Applied Physiology, Vol 75, Issue 1 273-278, Copyright © 1993 by American Physiological Society

ARTICLES

Effect of indomethacin on the pressor responses to sustained isometric contraction in humans

K. P. Davy, W. G. Herbert and J. H. Williams
Laboratory for Exercise, Sport, and Work Physiology, Virginia Polytechnic Institute and State University, Blacksburg 24061.

The purpose of this study was to test the hypothesis that prostaglandins participate in metaboreceptor stimulation of the pressor response to sustained isometric handgrip contraction in humans. To accomplish this, mean arterial pressure, heart rate (n = 10), and plasma norepinephrine levels (n = 8) were measured in healthy male subjects during sustained isometric handgrip at 40% of maximal voluntary contraction force to exhaustion and during a period of postcontraction muscle ischemia. The subjects were given a double-blind and counterbalanced administration of placebo or a single 100-mg dose of indomethacin. A period of 1 wk was allowed for systemic clearance of the drug. Mean arterial pressure increased 25 +/- 5 vs. 22 +/- 4 mmHg during the final minute of isometric handgrip contraction and 26 +/- 2 vs. 21 +/- 5 during the last minute of postcontraction muscle ischemia in the placebo vs. the indomethacin trial (P > 0.05), respectively. Heart rate was increased 21 +/- 4 vs. 17 +/- 3 beats/min during the final minute of isometric handgrip contraction in the placebo vs. the indomethacin trial (P > 0.05), respectively, and returned to control values during postcontraction muscle ischemia. Plasma norepinephrine levels increased 343 +/- 89 vs. 289 +/- 89 pg/ml after isometric handgrip contraction and 675 +/- 132 vs. 632 +/- 132 pg/ml after postcontraction muscle ischemia (P > 0.05) in the placebo vs. the indomethacin trial, respectively. These results suggest that prostaglandin inhibition does not significantly modulate muscle contraction-induced stimulation of mean arterial pressure, heart rate, or plasma norepinephrine levels.

This article has been cited by other articles:

				A. Momen, J. Cui, P. McQuillan, and L. I. Sinoway Local prostaglandin blockade attenuates muscle mechanoreflex-mediated renal vasoconstriction during muscle stretch in humans Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2184 - H2190. [Abstract] [Full Text] [PDF]

				J. Cui, P. McQuillan, A. Momen, C. Blaha, R. Moradkhan, V. Mascarenhas, C. Hogeman, A. Krishnan, and L. I. Sinoway The role of the cyclooxygenase products in evoking sympathetic activation in exercise Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1861 - H1868. [Abstract] [Full Text] [PDF]

				S. G. Hayes, A. E. Kindig, and M. P. Kaufman Cyclooxygenase blockade attenuates responses of group III and IV muscle afferents to dynamic exercise in cats Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2239 - H2246. [Abstract] [Full Text] [PDF]

				H. R. Middlekauff and J. Chiu Cyclooxygenase products sensitize muscle mechanoreceptors in healthy humans Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1944 - H1949. [Abstract] [Full Text] [PDF]

				K. J. Doerzbacher and C. A. Ray Muscle sympathetic nerve responses to physiological changes in prostaglandin production in humans J Appl Physiol, February 1, 2001; 90(2): 624 - 629. [Abstract] [Full Text] [PDF]